インターフェロン市場は2023年から2028年に26億5,000万米ドル、予測期間中のCAGRは4.65％で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、ウイルス感染症の増加、自己免疫疾患の症例の増加、組換え型インターフェロンの開発におけるバイオテクノロジーの進歩によって牽引されています。
本調査では、今後数年間のインターフェロン市場の成長を牽引する主な要因の一つとして、インターフェロンと他の薬剤クラスを含む併用療法の探求を挙げています。また、個別化医療が重視されるようになり、バイオシミラーに対する需要が増加していることも、市場の大きな需要につながると思われます。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global interferons market 2018 - 2022
4.2 Type Segment Analysis 2018 - 2022
4.3 Indication Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by Type
6.1 Market segments
6.2 Comparison by Type
6.3 Interferon beta - Market size and forecast 2023-2028
6.4 Interferon alfa - Market size and forecast 2023-2028
6.5 Interferon gamma - Market size and forecast 2023-2028
6.6 Market opportunity by Type
7 Market Segmentation by Indication
7.1 Market segments
7.2 Comparison by Indication
7.3 Multiple sclerosis - Market size and forecast 2023-2028
7.4 Hepatitis C - Market size and forecast 2023-2028
7.5 Melanoma - Market size and forecast 2023-2028
7.6 Leukemia - Market size and forecast 2023-2028
7.7 Other indications - Market size and forecast 2023-2028
7.8 Market opportunity by Indication
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 UK - Market size and forecast 2023-2028
9.9 China - Market size and forecast 2023-2028
9.10 Germany - Market size and forecast 2023-2028
9.11 Japan - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 3SBio Inc.
12.4 Bayer AG
12.5 Biogen Inc.
12.6 Biosidus SA
12.7 Bristol Myers Squibb Co.
12.8 F. Hoffmann La Roche Ltd.
12.9 Mega Labs SA
12.10 Merck KGaA
12.11 NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC
12.12 Novartis AG
12.13 Pfizer Inc.
12.14 PharmaEssentia Corp.
12.15 Sanfer
12.16 Synairgen plc
12.17 Zydus Lifesciences Ltd.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global interferons market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Indication Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Interferon beta - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Interferon beta - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Interferon beta - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Interferon beta - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Interferon alfa - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Interferon alfa - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Interferon alfa - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Interferon alfa - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Interferon gamma - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Interferon gamma - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Interferon gamma - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Interferon gamma - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Type ($ billion)
Exhibits47: Data Table on Market opportunity by Type ($ billion)
Exhibits48: Chart on Indication - Market share 2023-2028 (%)
Exhibits49: Data Table on Indication - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Indication
Exhibits51: Data Table on Comparison by Indication
Exhibits52: Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Hepatitis C - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Hepatitis C - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Hepatitis C - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Hepatitis C - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Melanoma - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Melanoma - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Melanoma - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Melanoma - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Leukemia - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Leukemia - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Leukemia - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Leukemia - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Other indications - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Other indications - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Other indications - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Other indications - Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by Indication ($ billion)
Exhibits73: Data Table on Market opportunity by Indication ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: 3SBio Inc. - Overview
Exhibits124: 3SBio Inc. - Product / Service
Exhibits125: 3SBio Inc. - Key offerings
Exhibits126: Bayer AG - Overview
Exhibits127: Bayer AG - Business segments
Exhibits128: Bayer AG - Key news
Exhibits129: Bayer AG - Key offerings
Exhibits130: Bayer AG - Segment focus
Exhibits131: Biogen Inc. - Overview
Exhibits132: Biogen Inc. - Product / Service
Exhibits133: Biogen Inc. - Key news
Exhibits134: Biogen Inc. - Key offerings
Exhibits135: Biosidus SA - Overview
Exhibits136: Biosidus SA - Product / Service
Exhibits137: Biosidus SA - Key offerings
Exhibits138: Bristol Myers Squibb Co. - Overview
Exhibits139: Bristol Myers Squibb Co. - Product / Service
Exhibits140: Bristol Myers Squibb Co. - Key news
Exhibits141: Bristol Myers Squibb Co. - Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. - Overview
Exhibits143: F. Hoffmann La Roche Ltd. - Business segments
Exhibits144: F. Hoffmann La Roche Ltd. - Key news
Exhibits145: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits146: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits147: Mega Labs SA - Overview
Exhibits148: Mega Labs SA - Product / Service
Exhibits149: Mega Labs SA - Key offerings
Exhibits150: Merck KGaA - Overview
Exhibits151: Merck KGaA - Business segments
Exhibits152: Merck KGaA - Key news
Exhibits153: Merck KGaA - Key offerings
Exhibits154: Merck KGaA - Segment focus
Exhibits155: NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC - Overview
Exhibits156: NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC - Product / Service
Exhibits157: NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC - Key offerings
Exhibits158: Novartis AG - Overview
Exhibits159: Novartis AG - Business segments
Exhibits160: Novartis AG - Key news
Exhibits161: Novartis AG - Key offerings
Exhibits162: Novartis AG - Segment focus
Exhibits163: Pfizer Inc. - Overview
Exhibits164: Pfizer Inc. - Product / Service
Exhibits165: Pfizer Inc. - Key news
Exhibits166: Pfizer Inc. - Key offerings
Exhibits167: PharmaEssentia Corp. - Overview
Exhibits168: PharmaEssentia Corp. - Product / Service
Exhibits169: PharmaEssentia Corp. - Key offerings
Exhibits170: Sanfer - Overview
Exhibits171: Sanfer - Product / Service
Exhibits172: Sanfer - Key offerings
Exhibits173: Synairgen plc - Overview
Exhibits174: Synairgen plc - Product / Service
Exhibits175: Synairgen plc - Key offerings
Exhibits176: Zydus Lifesciences Ltd. - Overview
Exhibits177: Zydus Lifesciences Ltd. - Business segments
Exhibits178: Zydus Lifesciences Ltd. - Key offerings
Exhibits179: Zydus Lifesciences Ltd. - Segment focus
Exhibits180: Inclusions checklist
Exhibits181: Exclusions checklist
Exhibits182: Currency conversion rates for US$
Exhibits183: Research methodology
Exhibits184: Validation techniques employed for market sizing
Exhibits185: Information sources
Exhibits186: List of abbreviations
